Live Breaking News & Updates on Oral Paclitaxel|Page 4

Stay updated with breaking news from Oral paclitaxel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ATNX ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Athenex, Inc. – ATNX


Home / Top News / ATNX ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Athenex, Inc. – ATNX
ATNX ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Athenex, Inc. – ATNX
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”).
To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=athenex-inc&id=2652 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action. ....

New York , United States , Sophie Zhang , Company Phase , Athenex Inc , Zhang Investor Law , Class Period , Oral Paclitaxel , Encequidar New Drug Application , Investor Law , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சோஃபி ஜாங் , நிறுவனம் கட்டம் , ஜாங் முதலீட்டாளர் சட்டம் , வர்க்கம் காலம் , முதலீட்டாளர் சட்டம் ,

ATNX 2-WEEK DEADLINE ALERT: HAGENS BERMAN Urges Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Class Action Deadline Approaching


Home / Top News / ATNX 2-WEEK DEADLINE ALERT: HAGENS BERMAN Urges Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Class Action Deadline Approaching
ATNX 2-WEEK DEADLINE ALERT: HAGENS BERMAN Urges Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Class Action Deadline Approaching
SAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Athenex, Inc.
(NASDAQ: ATNX) investors with significant losses to submit your losses now.
Class Period: Aug. 7, 2019 – Feb. 26, 2021
Lead Plaintiff Deadline: May 3, 2021
Visit: www.hbsslaw.com/investor-fraud/ATNX
Athenex, Inc. (NASDAQ: ATNX) Securities Class Action:
The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. ....

Hagens Berman , Reed Kathrein , Company Phase , Athenex Inc , Plaintiff Deadline , Securities Class Action , Class Period , Oral Paclitaxel , Encequidar New Drug Application , கென்ஸ் பெர்மன் , நிறுவனம் கட்டம் , பத்திரங்கள் வர்க்கம் நடவடிக்கை , வர்க்கம் காலம் ,